Calculate your absolute neutrophil count from CBC with differential. Includes ALC, AMC, AEC, severity grading, febrile neutropenia risk, and causes of neutropenia.
The ANC (Absolute Neutrophil Count) Calculator computes the absolute neutrophil count from a CBC with differential, then shows standard severity bands and the other major absolute white-cell counts for context. It is most useful when you need to translate a differential into the absolute counts that guide neutropenia interpretation.
The ANC is calculated by multiplying the total white blood cell count by the combined percentage of mature neutrophils (segmented) and immature neutrophils (bands). An ANC below 1500 cells/µL defines neutropenia, while more severe reductions carry progressively higher infection risk and need to be interpreted in the patient’s full clinical setting.
This calculator computes all absolute differential counts (ANC, ALC, AMC, AEC, ABC), validates the differential percentage total, and classifies neutropenia severity using standard thresholds. The differential tables on the page are there to support interpretation, not to replace clinician review of the CBC, treatment context, or infection workup.
CBC differentials are often reported as percentages, but neutropenia severity depends on the absolute count. This page turns the differential into the absolute counts directly and keeps the standard severity bands visible so the result is easier to interpret consistently.
ANC = WBC (cells/µL) × (% Neutrophils + % Bands) / 100 ALC = WBC × % Lymphocytes / 100 AMC = WBC × % Monocytes / 100 AEC = WBC × % Eosinophils / 100 ABC = WBC × % Basophils / 100
Result: ANC = 2,900/µL — Normal. ALC = 1,500/µL, AMC = 350/µL, AEC = 150/µL.
WBC 5,000/µL × (55% + 3%) = 2,900/µL. This is a normal ANC (≥1,500). All absolute counts are within normal ranges.
The ANC is checked in numerous clinical scenarios: routine pre-chemotherapy labs, fever workup in immunosuppressed patients, medication monitoring (clozapine requires regular ANC), evaluation of recurrent infections, and as part of the complete blood count interpretation. Understanding the ANC and its implications is fundamental to clinical medicine.
Febrile neutropenia is one of the most important ANC-related situations because infection risk rises sharply at very low neutrophil counts. This page is not a febrile-neutropenia order set; it only helps translate the CBC into absolute counts so users can recognize when the local oncology or hospital pathway should guide the response.
Understanding normal ranges helps interpret abnormalities. Neutrophils: 40-70% (2,000-7,000/µL); Lymphocytes: 20-40% (1,000-4,000/µL); Monocytes: 2-8% (200-800/µL); Eosinophils: 1-4% (100-500/µL); Basophils: 0-1% (0-100/µL). Children have different normal ranges with relative lymphocyte predominance until age 6-8.
Last updated:
This page calculates absolute neutrophil count from the CBC differential as "WBC × (segmented neutrophils + bands) / 100", then reports the result in cells per microliter with the standard neutropenia severity bands. It also calculates the other absolute white-cell counts so the differential can be read as counts rather than percentages alone.
The page is designed to support CBC interpretation, not to replace clinical management decisions. Fever, chemotherapy timing, marrow disease, medications, and infection status can materially change what the count means in practice, so the severity labels should be read as reference bands rather than a treatment order set.
Normal ANC is ≥1,500 cells/µL (some references use ≥2,000). Mild neutropenia: 1,000-1,499, moderate: 500-999, severe: <500, very severe/agranulocytosis: <200.
Febrile neutropenia is defined as ANC <500 (or expected to fall below 500) with a single temperature ≥38.3°C (101°F) or sustained ≥38°C (100.4°F) for 1 hour. It is an urgent clinical situation that should be evaluated under the local oncology or hospital pathway.
Yes, both mature (segmented) and immature (band) neutrophils are included. Some labs report bands separately, others do not differentiate.
Some populations (especially those of African, Middle Eastern, or Caribbean descent) have constitutionally lower ANCs (1,000-1,500) without increased infection risk. This is due to DARC gene variant and requires no treatment.
Granulocyte colony-stimulating factor (G-CSF, filgrastim or pegfilgrastim) is used prophylactically when chemo regimens have >20% febrile neutropenia risk, or therapeutically for ANC <500 with documented infection.
A left shift (increased bands >10%) indicates the bone marrow is releasing immature neutrophils in response to infection or inflammation, even if the total ANC appears normal or elevated.